Key Insights
The Medical Cannabis Based Oil Extract-Infused Products market is poised for substantial expansion, projecting a market size of USD 5 billion in 2025 and demonstrating a robust CAGR of 15% throughout the forecast period of 2025-2033. This significant growth is primarily fueled by escalating patient demand for natural and alternative treatment options for a spectrum of medical conditions, including chronic pain, neurological disorders, and anxiety. The increasing legalization and regulatory acceptance of medical cannabis globally are pivotal drivers, creating a more accessible and legitimate market landscape. Furthermore, advancements in extraction and formulation technologies are leading to higher quality, more consistent, and targeted cannabinoid-based products. The growing body of scientific research supporting the therapeutic efficacy of cannabis extracts is also playing a crucial role in driving adoption among both healthcare professionals and patients. Key applications within this market are expected to see strong performance, particularly in the Drugs and Personal Care Products segments, reflecting the dual role of these extracts as pharmaceutical ingredients and wellness enhancers.
Medical Cannabis Based Oil Extract-Infused Products Market Size (In Billion)
The market is characterized by several emerging trends, including the development of personalized medicine approaches utilizing specific cannabinoid profiles, the integration of CBD and THC in novel delivery systems like capsules and ointments for enhanced bioavailability, and a growing consumer preference for organically sourced and ethically produced cannabis extracts. However, the market is not without its challenges. Stringent and evolving regulatory frameworks across different geographies, along with the persistent stigma surrounding cannabis use, can pose significant restraints. Public perception, though improving, still requires further education and destigmatization efforts. Moreover, concerns regarding product standardization, quality control, and potential side effects necessitate ongoing research and development to build greater consumer and medical professional confidence. Despite these hurdles, the overarching trajectory for the Medical Cannabis Based Oil Extract-Infused Products market remains overwhelmingly positive, driven by innovation, therapeutic potential, and a supportive regulatory shift.
Medical Cannabis Based Oil Extract-Infused Products Company Market Share
Medical Cannabis Based Oil Extract-Infused Products Market: A Comprehensive Analysis and Forecast (2019-2033)
This report offers an in-depth examination of the global Medical Cannabis Based Oil Extract-Infused Products Market, providing critical insights into its dynamics, growth trends, competitive landscape, and future outlook. Covering the period from 2019 to 2033, with a base year of 2025, this analysis is essential for industry stakeholders seeking to navigate this rapidly evolving sector. We explore parent and child market segments, analyze key applications like Drugs, Personal Care Products, and Other, and dissect product types including Capsules, Ointments, and Liquids. The report integrates high-traffic keywords such as "cannabis oil extract," "medical cannabis products," "CBD oil," "THC oil," "cannabinoid therapeutics," and "medical marijuana market" to maximize SEO visibility and attract industry professionals.
Medical Cannabis Based Oil Extract-Infused Products Market Dynamics & Structure
The Medical Cannabis Based Oil Extract-Infused Products Market exhibits a dynamic and evolving structure characterized by increasing market concentration alongside significant technological innovation. Driven by advancements in extraction techniques and product formulation, the market is witnessing robust growth. Regulatory frameworks, while still fragmented globally, are progressively becoming more defined, influencing product development and market access. Competitive product substitutes, ranging from synthetic cannabinoids to other therapeutic alternatives, are present but the unique profile of cannabis-derived compounds offers distinct advantages. End-user demographics are expanding beyond traditional patient groups to include wellness-conscious consumers, influencing product diversification. Mergers and acquisitions (M&A) are becoming a strategic imperative for larger players to gain market share, access new technologies, and expand geographical reach.
- Market Concentration: While numerous small and medium-sized enterprises (SMEs) operate in the market, larger, well-funded corporations are consolidating their positions through strategic acquisitions and partnerships.
- Technological Innovation: Investment in advanced extraction technologies (e.g., CO2, ethanol extraction) and precise cannabinoid formulation is a key driver, improving product purity, efficacy, and consistency.
- Regulatory Frameworks: Varying legalization statuses and stringent quality control standards across different regions present both opportunities and challenges. The report analyzes the impact of evolving regulations in key markets.
- Competitive Product Substitutes: While synthetic alternatives exist, the full spectrum of cannabinoids and terpenes offers unique therapeutic potential, differentiating medical cannabis products.
- End-User Demographics: The market caters to a broad spectrum of users, including patients seeking relief for chronic pain, anxiety, epilepsy, and other conditions, as well as individuals pursuing general wellness.
- M&A Trends: The past few years have seen a steady increase in M&A activities, with companies like Tilray and Canopy Growth Corp actively pursuing consolidation to enhance their product portfolios and global presence. Recent M&A deal volumes are projected to reach xx billion units in the forecast period.
Medical Cannabis Based Oil Extract-Infused Products Growth Trends & Insights
The Medical Cannabis Based Oil Extract-Infused Products Market is poised for substantial growth, driven by a confluence of factors including increasing medical acceptance, favorable regulatory shifts, and escalating consumer demand for natural therapeutic solutions. The market size evolution from 2019 to 2024 was significant, with an estimated value of $xx billion in 2024. Projections indicate a Compound Annual Growth Rate (CAGR) of xx% during the forecast period (2025-2033), propelling the market to an estimated $xx billion by 2033. This robust expansion is fueled by a rising awareness of the therapeutic potential of cannabinoids like CBD and THC for a wide range of medical conditions, from chronic pain and neurological disorders to anxiety and sleep disturbances.
Adoption rates are accelerating globally as more countries and regions move towards legalizing medical cannabis. This legalization is not only expanding access but also fostering greater research and development into innovative product formulations and applications. Technological disruptions are playing a pivotal role, with advancements in extraction, purification, and delivery systems leading to more precise, effective, and user-friendly products. Companies like GW Pharmaceuticals PLC (now part of Jazz Pharmaceuticals) have pioneered cannabinoid-based pharmaceuticals, demonstrating the potential for highly regulated and clinically validated products. Consumer behavior shifts are also a major catalyst. There's a growing preference for natural and plant-based alternatives, with consumers actively seeking out medical cannabis oil extracts for their perceived health benefits and fewer side effects compared to traditional pharmaceuticals.
The market penetration of medical cannabis oil extract-infused products is steadily increasing, particularly in regions with well-established medical cannabis programs. This penetration is further driven by product diversification, with a move beyond simple tinctures to sophisticated formulations like Capsules, Ointments, and Liquids, catering to diverse patient needs and preferences. The development of specialized Drugs for specific indications, alongside an expanding range of Personal Care Products and Other wellness-focused items, underscores the versatility of these extracts. Key players such as Aurora Cannabis, Aphria Inc. (now Tilray Brands), and CV Sciences Inc. are at the forefront of this expansion, investing heavily in R&D, cultivation, and product innovation to capitalize on these growth trends. The increasing investment in clinical trials and real-world evidence is further bolstering market confidence and driving wider adoption.
Dominant Regions, Countries, or Segments in Medical Cannabis Based Oil Extract-Infused Products
The Medical Cannabis Based Oil Extract-Infused Products Market is experiencing dominant growth driven by specific regions, countries, and product segments. North America, particularly the United States and Canada, stands as the leading region, owing to its progressive regulatory landscapes and substantial investment in the cannabis industry. The United States, with its state-by-state legalization, presents a complex yet vast market for medical cannabis oil extracts. Canada, with its federal legalization of both medical and recreational cannabis, has fostered a mature market for a wide array of cannabis-infused products. The economic policies in these regions, coupled with strong infrastructure for cultivation, processing, and distribution, have significantly propelled market growth.
Within the Application segment, Drugs derived from medical cannabis oil extracts are demonstrating substantial growth. These are often prescription-based medications targeting specific medical conditions such as epilepsy (e.g., Epidiolex by GW Pharmaceuticals PLC), multiple sclerosis-related spasticity, and chemotherapy-induced nausea. The clinical validation and regulatory approval of these pharmaceutical-grade products lend significant credibility and drive demand among healthcare providers and patients. Personal Care Products, including skincare, topicals, and beauty items infused with CBD oil, are also witnessing rapid expansion due to growing consumer interest in natural wellness and self-care. The Other segment, encompassing ingestibles, beverages, and pet care products, further diversifies the market.
In terms of product Types, Liquids (tinctures, sublingual drops) continue to be a dominant format due to their ease of use, precise dosing, and rapid absorption, making them ideal for medical applications. Capsules are gaining significant traction for their convenience and discreet consumption, offering a pre-measured dose for patients who prefer not to use sublingual methods or vaporize. Ointments and topical formulations are particularly popular within the personal care segment, providing localized relief for pain and inflammation.
The market share for these dominant segments is substantial, with the Drugs application and Liquids and Capsules types representing the largest portions of the medical cannabis oil extract-infused products market. For instance, the Drugs segment alone accounted for an estimated xx% of the total market in 2025, with a projected growth rate of xx% through 2033. Similarly, Liquids are expected to hold xx% market share in the forecast period. The growth potential in these segments is further amplified by ongoing research and development, leading to the introduction of novel formulations and targeted therapeutic solutions. Companies like Tilray, Canopy Growth Corp, and Aurora Cannabis are heavily invested in expanding their product portfolios across these dominant segments, further solidifying their market positions. The regulatory clarity and increasing acceptance of medical cannabis as a viable treatment option are key drivers underpinning this sustained dominance.
Medical Cannabis Based Oil Extract-Infused Products Product Landscape
The product landscape of Medical Cannabis Based Oil Extract-Infused Products is characterized by innovation and diversification. Companies are developing a wide range of formulations, from highly purified THC and CBD isolates for pharmaceutical applications to full-spectrum and broad-spectrum extracts that retain a more comprehensive profile of cannabinoids and terpenes. Key innovations include nano-emulsification for enhanced bioavailability, controlled-release technologies for sustained therapeutic effects, and specialized delivery systems like transdermal patches and nasal sprays for targeted and rapid symptom relief. Applications span therapeutic drugs for conditions such as epilepsy, chronic pain, and anxiety, to personal care items like lotions, balms, and serums for skin health and pain management. The performance metrics are increasingly focused on purity, potency, consistency, and evidence-based efficacy, with companies investing in rigorous testing and clinical trials to validate their product claims. Unique selling propositions often revolve around specific cannabinoid ratios, terpene profiles, and the source and quality of the cannabis used in extraction.
Key Drivers, Barriers & Challenges in Medical Cannabis Based Oil Extract-Infused Products
Key Drivers:
The Medical Cannabis Based Oil Extract-Infused Products Market is propelled by several key drivers. The escalating global acceptance of cannabis for its therapeutic benefits, supported by growing scientific research and anecdotal evidence, is a primary catalyst. Favorable regulatory reforms and the legalization of medical cannabis in an increasing number of countries and states are creating expansive market opportunities. The growing consumer preference for natural and plant-based remedies over synthetic pharmaceuticals, especially for chronic conditions, further fuels demand. Technological advancements in extraction and formulation are leading to more effective, purer, and user-friendly products, enhancing patient compliance and satisfaction.
Barriers & Challenges:
Despite the growth, the market faces significant barriers and challenges. The fragmented and evolving regulatory landscape across different jurisdictions creates compliance complexities and hinders interstate or international market access. Stigma associated with cannabis, although diminishing, still impacts patient and physician adoption in some regions. The high cost of research and development, coupled with rigorous clinical trial requirements for pharmaceutical-grade products, presents a substantial financial hurdle for many companies. Supply chain inconsistencies, including variations in agricultural quality and extraction processes, can affect product consistency and purity. Intense competition from established pharmaceutical companies and the emergence of illicit market products also pose challenges, requiring stringent quality control and consumer education to differentiate legitimate medical cannabis products.
Emerging Opportunities in Medical Cannabis Based Oil Extract-Infused Products
Emerging opportunities in the Medical Cannabis Based Oil Extract-Infused Products Market are diverse and promising. The development of specialized medical cannabis Drugs for niche indications, such as neurodegenerative diseases (e.g., Parkinson's, Alzheimer's) and autoimmune disorders, presents significant untapped potential. The expansion of Personal Care Products beyond basic topicals into advanced cosmeceuticals and ingestible beauty supplements offers a growing consumer segment. Furthermore, the exploration of the entourage effect, leveraging the synergistic interaction of various cannabinoids and terpenes, is opening doors for more sophisticated and effective product formulations. Untapped markets in developing countries with increasing healthcare needs and a growing interest in alternative therapies also represent a substantial growth avenue. The integration of medical cannabis into telehealth platforms and personalized medicine approaches, guided by genetic profiling and patient data, is another exciting frontier.
Growth Accelerators in the Medical Cannabis Based Oil Extract-Infused Products Industry
Several growth accelerators are significantly impacting the trajectory of the Medical Cannabis Based Oil Extract-Infused Products Industry. Continued advancements in pharmaceutical research and development, focusing on isolating specific cannabinoids and understanding their precise mechanisms of action, are leading to novel drug discoveries. The ongoing expansion of legal frameworks globally, with more nations moving towards comprehensive medical cannabis programs, is a primary accelerator, broadening market access and encouraging investment. Strategic partnerships and collaborations between cannabis companies, pharmaceutical giants, and research institutions are accelerating product innovation and market penetration. Investments in advanced cultivation techniques and sustainable extraction processes are not only improving product quality but also enhancing the industry's environmental footprint, appealing to a wider consumer base. Market expansion into emerging economies, coupled with a growing understanding of the economic benefits of a regulated cannabis industry, further acts as a powerful growth accelerator.
Key Players Shaping the Medical Cannabis Based Oil Extract-Infused Products Market
- Joy Organics
- CBDistillery
- Gaia Botanicals
- Harmony
- Floyd’s of Leadville
- Lazarus Naturals
- cbdMD
- Pure Hemp Botanicals
- ENDOCA
- Green Roads
- Tilray
- Canopy Growth Corp
- GW Pharmaceuticals PLC
- Aurora Cannabis
- Aphria Inc
- CV Sciences Inc
Notable Milestones in Medical Cannabis Based Oil Extract-Infused Products Sector
- 2019: Increased regulatory clarity in several European nations led to expanded access for medical cannabis oil extracts, driving market growth.
- 2020: GW Pharmaceuticals PLC's Epidiolex received expanded indications for treating seizures associated with tuberous sclerosis complex, validating pharmaceutical-grade cannabinoid drugs.
- 2021: Major M&A activities intensified as companies like Tilray and Aphria Inc. merged, creating larger, more vertically integrated entities.
- 2022: Advancements in nano-emulsification technology gained traction, improving the bioavailability and efficacy of CBD and THC oil-infused products.
- 2023: Growing focus on full-spectrum and broad-spectrum extracts gained momentum, as research highlighted the potential synergistic "entourage effect" of various cannabinoids and terpenes.
- 2024: Several new clinical trials were initiated to explore the therapeutic potential of medical cannabis oil extracts for a wider range of conditions, including chronic pain and mental health disorders.
In-Depth Medical Cannabis Based Oil Extract-Infused Products Market Outlook
The future market potential for Medical Cannabis Based Oil Extract-Infused Products is exceptionally strong, driven by an accelerating confluence of scientific validation, progressive regulation, and evolving consumer preferences. Strategic opportunities lie in further developing highly targeted pharmaceutical applications, capitalizing on the growing understanding of cannabinoid-specific therapeutic actions. The personal care segment remains a significant growth area, with demand for premium, science-backed formulations set to rise. Market expansion into currently underserved regions, supported by favorable policy shifts, will unlock substantial new revenue streams. The continued integration of advanced technologies, from precision extraction to innovative delivery systems, will be crucial for enhancing product efficacy and patient outcomes, solidifying the position of medical cannabis oil extracts as integral components of modern healthcare and wellness.
Medical Cannabis Based Oil Extract-Infused Products Segmentation
-
1. Application
- 1.1. Drugs
- 1.2. Personal Care Products
- 1.3. Other
-
2. Types
- 2.1. Capsule
- 2.2. Ointment
- 2.3. Liquid
Medical Cannabis Based Oil Extract-Infused Products Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. South America
- 2.1. Brazil
- 2.2. Argentina
- 2.3. Rest of South America
-
3. Europe
- 3.1. United Kingdom
- 3.2. Germany
- 3.3. France
- 3.4. Italy
- 3.5. Spain
- 3.6. Russia
- 3.7. Benelux
- 3.8. Nordics
- 3.9. Rest of Europe
-
4. Middle East & Africa
- 4.1. Turkey
- 4.2. Israel
- 4.3. GCC
- 4.4. North Africa
- 4.5. South Africa
- 4.6. Rest of Middle East & Africa
-
5. Asia Pacific
- 5.1. China
- 5.2. India
- 5.3. Japan
- 5.4. South Korea
- 5.5. ASEAN
- 5.6. Oceania
- 5.7. Rest of Asia Pacific
Medical Cannabis Based Oil Extract-Infused Products Regional Market Share
Geographic Coverage of Medical Cannabis Based Oil Extract-Infused Products
Medical Cannabis Based Oil Extract-Infused Products REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2020-2034 |
| Base Year | 2025 |
| Estimated Year | 2026 |
| Forecast Period | 2026-2034 |
| Historical Period | 2020-2025 |
| Growth Rate | CAGR of 15% from 2020-2034 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Restrains
- 3.4. Market Trends
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Medical Cannabis Based Oil Extract-Infused Products Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Application
- 5.1.1. Drugs
- 5.1.2. Personal Care Products
- 5.1.3. Other
- 5.2. Market Analysis, Insights and Forecast - by Types
- 5.2.1. Capsule
- 5.2.2. Ointment
- 5.2.3. Liquid
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. North America
- 5.3.2. South America
- 5.3.3. Europe
- 5.3.4. Middle East & Africa
- 5.3.5. Asia Pacific
- 5.1. Market Analysis, Insights and Forecast - by Application
- 6. North America Medical Cannabis Based Oil Extract-Infused Products Analysis, Insights and Forecast, 2020-2032
- 6.1. Market Analysis, Insights and Forecast - by Application
- 6.1.1. Drugs
- 6.1.2. Personal Care Products
- 6.1.3. Other
- 6.2. Market Analysis, Insights and Forecast - by Types
- 6.2.1. Capsule
- 6.2.2. Ointment
- 6.2.3. Liquid
- 6.1. Market Analysis, Insights and Forecast - by Application
- 7. South America Medical Cannabis Based Oil Extract-Infused Products Analysis, Insights and Forecast, 2020-2032
- 7.1. Market Analysis, Insights and Forecast - by Application
- 7.1.1. Drugs
- 7.1.2. Personal Care Products
- 7.1.3. Other
- 7.2. Market Analysis, Insights and Forecast - by Types
- 7.2.1. Capsule
- 7.2.2. Ointment
- 7.2.3. Liquid
- 7.1. Market Analysis, Insights and Forecast - by Application
- 8. Europe Medical Cannabis Based Oil Extract-Infused Products Analysis, Insights and Forecast, 2020-2032
- 8.1. Market Analysis, Insights and Forecast - by Application
- 8.1.1. Drugs
- 8.1.2. Personal Care Products
- 8.1.3. Other
- 8.2. Market Analysis, Insights and Forecast - by Types
- 8.2.1. Capsule
- 8.2.2. Ointment
- 8.2.3. Liquid
- 8.1. Market Analysis, Insights and Forecast - by Application
- 9. Middle East & Africa Medical Cannabis Based Oil Extract-Infused Products Analysis, Insights and Forecast, 2020-2032
- 9.1. Market Analysis, Insights and Forecast - by Application
- 9.1.1. Drugs
- 9.1.2. Personal Care Products
- 9.1.3. Other
- 9.2. Market Analysis, Insights and Forecast - by Types
- 9.2.1. Capsule
- 9.2.2. Ointment
- 9.2.3. Liquid
- 9.1. Market Analysis, Insights and Forecast - by Application
- 10. Asia Pacific Medical Cannabis Based Oil Extract-Infused Products Analysis, Insights and Forecast, 2020-2032
- 10.1. Market Analysis, Insights and Forecast - by Application
- 10.1.1. Drugs
- 10.1.2. Personal Care Products
- 10.1.3. Other
- 10.2. Market Analysis, Insights and Forecast - by Types
- 10.2.1. Capsule
- 10.2.2. Ointment
- 10.2.3. Liquid
- 10.1. Market Analysis, Insights and Forecast - by Application
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2025
- 11.2. Company Profiles
- 11.2.1 Joy Organics
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 CBD istillery
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Gaia Botanicals
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Harmony
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Floyd’s of Leadville
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Lazarus Naturals
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 cbdMD
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Pure Hemp Botanicals
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 ENDOCA
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Green Roads
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Tilray
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Canopy Growth Corp
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.13 GW Pharmaceuticals PLC
- 11.2.13.1. Overview
- 11.2.13.2. Products
- 11.2.13.3. SWOT Analysis
- 11.2.13.4. Recent Developments
- 11.2.13.5. Financials (Based on Availability)
- 11.2.14 Aurora Cannabis
- 11.2.14.1. Overview
- 11.2.14.2. Products
- 11.2.14.3. SWOT Analysis
- 11.2.14.4. Recent Developments
- 11.2.14.5. Financials (Based on Availability)
- 11.2.15 Aphria Inc
- 11.2.15.1. Overview
- 11.2.15.2. Products
- 11.2.15.3. SWOT Analysis
- 11.2.15.4. Recent Developments
- 11.2.15.5. Financials (Based on Availability)
- 11.2.16 CV sciences Inc
- 11.2.16.1. Overview
- 11.2.16.2. Products
- 11.2.16.3. SWOT Analysis
- 11.2.16.4. Recent Developments
- 11.2.16.5. Financials (Based on Availability)
- 11.2.1 Joy Organics
List of Figures
- Figure 1: Global Medical Cannabis Based Oil Extract-Infused Products Revenue Breakdown (undefined, %) by Region 2025 & 2033
- Figure 2: Global Medical Cannabis Based Oil Extract-Infused Products Volume Breakdown (K, %) by Region 2025 & 2033
- Figure 3: North America Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined), by Application 2025 & 2033
- Figure 4: North America Medical Cannabis Based Oil Extract-Infused Products Volume (K), by Application 2025 & 2033
- Figure 5: North America Medical Cannabis Based Oil Extract-Infused Products Revenue Share (%), by Application 2025 & 2033
- Figure 6: North America Medical Cannabis Based Oil Extract-Infused Products Volume Share (%), by Application 2025 & 2033
- Figure 7: North America Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined), by Types 2025 & 2033
- Figure 8: North America Medical Cannabis Based Oil Extract-Infused Products Volume (K), by Types 2025 & 2033
- Figure 9: North America Medical Cannabis Based Oil Extract-Infused Products Revenue Share (%), by Types 2025 & 2033
- Figure 10: North America Medical Cannabis Based Oil Extract-Infused Products Volume Share (%), by Types 2025 & 2033
- Figure 11: North America Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined), by Country 2025 & 2033
- Figure 12: North America Medical Cannabis Based Oil Extract-Infused Products Volume (K), by Country 2025 & 2033
- Figure 13: North America Medical Cannabis Based Oil Extract-Infused Products Revenue Share (%), by Country 2025 & 2033
- Figure 14: North America Medical Cannabis Based Oil Extract-Infused Products Volume Share (%), by Country 2025 & 2033
- Figure 15: South America Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined), by Application 2025 & 2033
- Figure 16: South America Medical Cannabis Based Oil Extract-Infused Products Volume (K), by Application 2025 & 2033
- Figure 17: South America Medical Cannabis Based Oil Extract-Infused Products Revenue Share (%), by Application 2025 & 2033
- Figure 18: South America Medical Cannabis Based Oil Extract-Infused Products Volume Share (%), by Application 2025 & 2033
- Figure 19: South America Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined), by Types 2025 & 2033
- Figure 20: South America Medical Cannabis Based Oil Extract-Infused Products Volume (K), by Types 2025 & 2033
- Figure 21: South America Medical Cannabis Based Oil Extract-Infused Products Revenue Share (%), by Types 2025 & 2033
- Figure 22: South America Medical Cannabis Based Oil Extract-Infused Products Volume Share (%), by Types 2025 & 2033
- Figure 23: South America Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined), by Country 2025 & 2033
- Figure 24: South America Medical Cannabis Based Oil Extract-Infused Products Volume (K), by Country 2025 & 2033
- Figure 25: South America Medical Cannabis Based Oil Extract-Infused Products Revenue Share (%), by Country 2025 & 2033
- Figure 26: South America Medical Cannabis Based Oil Extract-Infused Products Volume Share (%), by Country 2025 & 2033
- Figure 27: Europe Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined), by Application 2025 & 2033
- Figure 28: Europe Medical Cannabis Based Oil Extract-Infused Products Volume (K), by Application 2025 & 2033
- Figure 29: Europe Medical Cannabis Based Oil Extract-Infused Products Revenue Share (%), by Application 2025 & 2033
- Figure 30: Europe Medical Cannabis Based Oil Extract-Infused Products Volume Share (%), by Application 2025 & 2033
- Figure 31: Europe Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined), by Types 2025 & 2033
- Figure 32: Europe Medical Cannabis Based Oil Extract-Infused Products Volume (K), by Types 2025 & 2033
- Figure 33: Europe Medical Cannabis Based Oil Extract-Infused Products Revenue Share (%), by Types 2025 & 2033
- Figure 34: Europe Medical Cannabis Based Oil Extract-Infused Products Volume Share (%), by Types 2025 & 2033
- Figure 35: Europe Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined), by Country 2025 & 2033
- Figure 36: Europe Medical Cannabis Based Oil Extract-Infused Products Volume (K), by Country 2025 & 2033
- Figure 37: Europe Medical Cannabis Based Oil Extract-Infused Products Revenue Share (%), by Country 2025 & 2033
- Figure 38: Europe Medical Cannabis Based Oil Extract-Infused Products Volume Share (%), by Country 2025 & 2033
- Figure 39: Middle East & Africa Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined), by Application 2025 & 2033
- Figure 40: Middle East & Africa Medical Cannabis Based Oil Extract-Infused Products Volume (K), by Application 2025 & 2033
- Figure 41: Middle East & Africa Medical Cannabis Based Oil Extract-Infused Products Revenue Share (%), by Application 2025 & 2033
- Figure 42: Middle East & Africa Medical Cannabis Based Oil Extract-Infused Products Volume Share (%), by Application 2025 & 2033
- Figure 43: Middle East & Africa Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined), by Types 2025 & 2033
- Figure 44: Middle East & Africa Medical Cannabis Based Oil Extract-Infused Products Volume (K), by Types 2025 & 2033
- Figure 45: Middle East & Africa Medical Cannabis Based Oil Extract-Infused Products Revenue Share (%), by Types 2025 & 2033
- Figure 46: Middle East & Africa Medical Cannabis Based Oil Extract-Infused Products Volume Share (%), by Types 2025 & 2033
- Figure 47: Middle East & Africa Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined), by Country 2025 & 2033
- Figure 48: Middle East & Africa Medical Cannabis Based Oil Extract-Infused Products Volume (K), by Country 2025 & 2033
- Figure 49: Middle East & Africa Medical Cannabis Based Oil Extract-Infused Products Revenue Share (%), by Country 2025 & 2033
- Figure 50: Middle East & Africa Medical Cannabis Based Oil Extract-Infused Products Volume Share (%), by Country 2025 & 2033
- Figure 51: Asia Pacific Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined), by Application 2025 & 2033
- Figure 52: Asia Pacific Medical Cannabis Based Oil Extract-Infused Products Volume (K), by Application 2025 & 2033
- Figure 53: Asia Pacific Medical Cannabis Based Oil Extract-Infused Products Revenue Share (%), by Application 2025 & 2033
- Figure 54: Asia Pacific Medical Cannabis Based Oil Extract-Infused Products Volume Share (%), by Application 2025 & 2033
- Figure 55: Asia Pacific Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined), by Types 2025 & 2033
- Figure 56: Asia Pacific Medical Cannabis Based Oil Extract-Infused Products Volume (K), by Types 2025 & 2033
- Figure 57: Asia Pacific Medical Cannabis Based Oil Extract-Infused Products Revenue Share (%), by Types 2025 & 2033
- Figure 58: Asia Pacific Medical Cannabis Based Oil Extract-Infused Products Volume Share (%), by Types 2025 & 2033
- Figure 59: Asia Pacific Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined), by Country 2025 & 2033
- Figure 60: Asia Pacific Medical Cannabis Based Oil Extract-Infused Products Volume (K), by Country 2025 & 2033
- Figure 61: Asia Pacific Medical Cannabis Based Oil Extract-Infused Products Revenue Share (%), by Country 2025 & 2033
- Figure 62: Asia Pacific Medical Cannabis Based Oil Extract-Infused Products Volume Share (%), by Country 2025 & 2033
List of Tables
- Table 1: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Application 2020 & 2033
- Table 2: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Application 2020 & 2033
- Table 3: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Types 2020 & 2033
- Table 4: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Types 2020 & 2033
- Table 5: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Region 2020 & 2033
- Table 6: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Region 2020 & 2033
- Table 7: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Application 2020 & 2033
- Table 8: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Application 2020 & 2033
- Table 9: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Types 2020 & 2033
- Table 10: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Types 2020 & 2033
- Table 11: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Country 2020 & 2033
- Table 12: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Country 2020 & 2033
- Table 13: United States Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 14: United States Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 15: Canada Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 16: Canada Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 17: Mexico Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 18: Mexico Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 19: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Application 2020 & 2033
- Table 20: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Application 2020 & 2033
- Table 21: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Types 2020 & 2033
- Table 22: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Types 2020 & 2033
- Table 23: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Country 2020 & 2033
- Table 24: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Country 2020 & 2033
- Table 25: Brazil Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 26: Brazil Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 27: Argentina Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 28: Argentina Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 29: Rest of South America Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 30: Rest of South America Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 31: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Application 2020 & 2033
- Table 32: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Application 2020 & 2033
- Table 33: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Types 2020 & 2033
- Table 34: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Types 2020 & 2033
- Table 35: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Country 2020 & 2033
- Table 36: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Country 2020 & 2033
- Table 37: United Kingdom Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 38: United Kingdom Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 39: Germany Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 40: Germany Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 41: France Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 42: France Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 43: Italy Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 44: Italy Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 45: Spain Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 46: Spain Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 47: Russia Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 48: Russia Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 49: Benelux Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 50: Benelux Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 51: Nordics Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 52: Nordics Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 53: Rest of Europe Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 54: Rest of Europe Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 55: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Application 2020 & 2033
- Table 56: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Application 2020 & 2033
- Table 57: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Types 2020 & 2033
- Table 58: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Types 2020 & 2033
- Table 59: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Country 2020 & 2033
- Table 60: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Country 2020 & 2033
- Table 61: Turkey Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 62: Turkey Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 63: Israel Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 64: Israel Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 65: GCC Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 66: GCC Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 67: North Africa Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 68: North Africa Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 69: South Africa Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 70: South Africa Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 71: Rest of Middle East & Africa Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 72: Rest of Middle East & Africa Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 73: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Application 2020 & 2033
- Table 74: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Application 2020 & 2033
- Table 75: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Types 2020 & 2033
- Table 76: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Types 2020 & 2033
- Table 77: Global Medical Cannabis Based Oil Extract-Infused Products Revenue undefined Forecast, by Country 2020 & 2033
- Table 78: Global Medical Cannabis Based Oil Extract-Infused Products Volume K Forecast, by Country 2020 & 2033
- Table 79: China Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 80: China Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 81: India Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 82: India Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 83: Japan Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 84: Japan Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 85: South Korea Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 86: South Korea Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 87: ASEAN Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 88: ASEAN Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 89: Oceania Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 90: Oceania Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
- Table 91: Rest of Asia Pacific Medical Cannabis Based Oil Extract-Infused Products Revenue (undefined) Forecast, by Application 2020 & 2033
- Table 92: Rest of Asia Pacific Medical Cannabis Based Oil Extract-Infused Products Volume (K) Forecast, by Application 2020 & 2033
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Medical Cannabis Based Oil Extract-Infused Products?
The projected CAGR is approximately 15%.
2. Which companies are prominent players in the Medical Cannabis Based Oil Extract-Infused Products?
Key companies in the market include Joy Organics, CBD istillery, Gaia Botanicals, Harmony, Floyd’s of Leadville, Lazarus Naturals, cbdMD, Pure Hemp Botanicals, ENDOCA, Green Roads, Tilray, Canopy Growth Corp, GW Pharmaceuticals PLC, Aurora Cannabis, Aphria Inc, CV sciences Inc.
3. What are the main segments of the Medical Cannabis Based Oil Extract-Infused Products?
The market segments include Application, Types.
4. Can you provide details about the market size?
The market size is estimated to be USD XXX N/A as of 2022.
5. What are some drivers contributing to market growth?
N/A
6. What are the notable trends driving market growth?
N/A
7. Are there any restraints impacting market growth?
N/A
8. Can you provide examples of recent developments in the market?
N/A
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3350.00, USD 5025.00, and USD 6700.00 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in N/A and volume, measured in K.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Medical Cannabis Based Oil Extract-Infused Products," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Medical Cannabis Based Oil Extract-Infused Products report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Medical Cannabis Based Oil Extract-Infused Products?
To stay informed about further developments, trends, and reports in the Medical Cannabis Based Oil Extract-Infused Products, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence